Taylor Morrison's Revenue Decline Meets Wall Street's Lowest Bar in Years
Taylor Morrison Home Corporation (TMHC) reports second-quarter 2026 earnings on July 22, 2026, with analysts expecting a sharp year-over-year decline as the homebuilder navigates a challenging housing market. The central question: can TMHC's recent track record of significant earnings beats offset deteriorating analyst sentiment and expectations for a 46% earnings decline from the prior year? With the stock trading near all-time highs despite weakening fundamentals, this report will test whether momentum can withstand mounting headwinds.
Part 1: Earnings Preview
Taylor Morrison Home Corporation is a leading U.S. homebuilder operating across multiple states, focusing on entry-level, move-up, and luxury single-family homes. The company generates revenue through home sales, land development, and financial services, making it sensitive to interest rates, housing demand, and construction costs.
TMHC reports earnings on July 22, 2026, with the consensus estimate calling for $1.09 per share for the second quarter ending June 2026. The company most recently reported $1.12 per share for the first quarter of 2026, delivering a substantial 36.59% beat versus the $0.82 estimate. However, the year-over-year comparison is stark: analysts expect Q2 2026 earnings to plunge 46.04% from the $2.02 reported in Q2 2025, reflecting significant pressure on the homebuilding sector.
Three key themes define this earnings story:
Housing Market Deterioration: The sharp year-over-year earnings decline reflects broader weakness in the U.S. housing market, with elevated mortgage rates, affordability constraints, and softening demand weighing on homebuilder margins and volumes. Investors will scrutinize order trends, cancellation rates, and pricing power.
Margin Compression: The dramatic earnings decline despite TMHC's recent operational execution suggests significant margin pressure from higher construction costs, land expenses, and incentives needed to move inventory. Management's commentary on gross margins and cost management will be critical.
Analyst Confidence Erosion: Despite TMHC's consistent earnings beats, analyst sentiment has deteriorated sharply over the past month, with the consensus recommendation weakening and price targets suggesting limited upside. This disconnect between execution and outlook raises questions about whether the company can sustain its outperformance.
Analysts heading into the release acknowledge TMHC's strong execution track record but express caution about the sustainability of results in a weakening housing environment. The consensus has been revised significantly lower, with full-year 2026 estimates now calling for $5.26, down 36.17% from the prior year's $8.24.
Part 2: Historical Earnings Performance
Taylor Morrison has established a consistent pattern of exceeding analyst expectations, delivering beats in each of the past four quarters. The company's most recent performance was particularly impressive, with the $1.12 Q1 2026 result surpassing estimates by 36.59%—the largest surprise in the recent series.
Looking at the year-ago pattern, TMHC reported $2.02 in Q2 2025, beating the $1.94 estimate by 4.12%. The subsequent quarters showed accelerating outperformance: Q3 2025 delivered a 9.33% beat, Q4 2025 posted a 10.40% beat, and Q1 2026 achieved the 36.59% surprise. This progression suggests improving operational execution and potentially conservative analyst modeling.
However, the magnitude of beats has coincided with absolute earnings volatility. While TMHC consistently exceeded expectations, reported EPS ranged from $1.12 to $2.11 across the four quarters, reflecting the seasonal and cyclical nature of homebuilding. The current $1.09 consensus for Q2 2026 represents a dramatic 46% decline from the $2.02 reported in the year-ago quarter, suggesting analysts expect the beat streak may not be enough to offset fundamental deterioration in the housing market.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Jun 2025 | $1.94 | $2.02 | +4.12% | Beat |
| Sep 2025 | $1.93 | $2.11 | +9.33% | Beat |
| Dec 2025 | $1.73 | $1.91 | +10.40% | Beat |
| Mar 2026 | $0.82 | $1.12 | +36.59% | Beat |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
Taylor Morrison typically reports earnings after market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to the actual numbers.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-04-22 | +$3.06 (+4.94%) | $3.81 (6.16%) | -$0.67 (-1.03%) | $1.92 (2.95%) |
| 2026-02-11 | -$0.71 (-1.07%) | $3.21 (4.83%) | -$0.23 (-0.35%) | $1.77 (2.69%) |
| 2025-10-22 | -$2.03 (-3.24%) | $2.95 (4.72%) | +$0.51 (+0.84%) | $1.82 (3.00%) |
| 2025-07-23 | -$2.51 (-3.76%) | $3.37 (5.04%) | -$3.59 (-5.58%) | $3.57 (5.54%) |
| 2025-04-23 | -$1.19 (-2.02%) | $4.36 (7.42%) | +$0.54 (+0.94%) | $1.63 (2.83%) |
| 2025-02-12 | +$2.06 (+3.30%) | $3.19 (5.11%) | -$0.50 (-0.78%) | $1.72 (2.67%) |
| 2024-10-23 | +$2.36 (+3.64%) | $2.22 (3.42%) | +$1.16 (+1.73%) | $1.45 (2.16%) |
| 2024-07-24 | -$0.35 (-0.53%) | $2.30 (3.49%) | -$0.06 (-0.09%) | $2.93 (4.47%) |
| Avg Abs Move | 2.81% | 5.02% | 1.42% | 3.29% |
TMHC's post-earnings price behavior shows significant volatility, with an average absolute Day 0 move of 2.81% and Day +1 move of 1.42%. The most recent earnings release on April 22, 2026, produced the largest reaction in the series—a 4.94% Day 0 surge followed by a 1.03% Day 1 decline, suggesting initial enthusiasm that partially reversed.
The historical pattern reveals mixed directional outcomes but consistent volatility. Day 0 moves have ranged from a 3.76% decline (July 2025) to a 4.94% gain (April 2026), with an average intraday range of 5.02%. Day 1 follow-through has been more muted, averaging 1.42% with a 3.29% range, though the July 2025 report produced an unusually large 5.58% Day 1 decline.
Investors should anticipate meaningful price movement around this release, with the stock historically moving roughly 3% to 5% in the immediate aftermath of earnings. The recent April 2026 report's strong Day 0 reaction followed by Day 1 reversal suggests the market may be quick to reassess initial reactions in the current environment.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 31) |
| Expected Move | $2.21 (3.05%) |
| Expected Range | $70.27 to $74.69 |
| Implied Volatility | 7.68% |
The options market is pricing a 3.05% expected move for the August 2026 expiration, slightly above the 2.81% average historical Day 0 move but below the 5.02% average Day 0 range. This suggests options traders are anticipating moderate volatility—consistent with recent history but not pricing in an outsized reaction despite the challenging fundamental backdrop.
Part 3: What Analysts Are Saying
Analyst sentiment toward Taylor Morrison has deteriorated significantly, with the consensus recommendation weakening from 3.11 (Hold/Buy) one month ago to 2.78 (Hold) currently. The rating distribution shifted notably, with zero Strong Buy or Moderate Buy ratings remaining, compared to one of each a month ago. The consensus now consists of 8 Hold ratings (up from 6) and 1 Strong Sell (unchanged), reflecting growing caution about the homebuilder's prospects.
The average price target of $67.00 implies 7.6% downside from the current $72.48 price, with estimates ranging from a low of $49.00 to a high of $73.00. This represents a significant disconnect between the stock's recent price strength and analyst expectations, with the mean target suggesting the market has priced in more optimism than fundamentals support.
The sentiment deterioration is particularly notable given TMHC's consistent earnings beats. Analysts appear to be looking past near-term execution strength and focusing on the challenging housing market backdrop, with the 46% year-over-year earnings decline expected for Q2 2026 and 36% decline projected for full-year 2026 reflecting concerns about sustainability. The shift from buy-rated coverage to predominantly hold-rated coverage over the past month suggests analysts believe the risk/reward has become less favorable at current levels, even as they acknowledge the company's operational track record.
Part 4: Technical Picture
Taylor Morrison enters earnings with exceptionally strong technical momentum, trading at $72.48 and positioned above all major moving averages. The stock sits above its 5-day ($72.22), 10-day ($72.05), 20-day ($71.93), 50-day ($67.58), 100-day ($63.94), and 200-day ($63.02) moving averages, indicating a well-established uptrend across all timeframes.
The Barchart Technical Opinion has strengthened recently, moving from 88% Buy one month ago to 100% Buy currently, where it has held for the past week. This maximum bullish reading reflects the stock's persistent upward momentum despite deteriorating fundamental expectations.
Timeframe Analysis:
- Short-term (100% Buy): Maximum buy signal indicates powerful near-term momentum heading into earnings
- Medium-term (100% Buy): Strong buy signal confirms the intermediate-term trend remains firmly positive
- Long-term (100% Buy): Maximum buy reading shows the longer-term trend structure is exceptionally bullish
Trend Characteristics: The combination of Maximum strength and Strongest direction signals an unusually powerful technical environment, with momentum aligned across all timeframes—a setup that historically supports continuation but also raises the stakes for any disappointment.
The stock has gained approximately 15% from its 50-day moving average and 13% from its 100-day average, indicating significant recent outperformance. However, this strength creates a challenging setup for earnings: while the technical picture is unambiguously bullish, the magnitude of the advance and the disconnect from analyst price targets ($67.00 mean target versus $72.48 current price) suggest limited room for error. The stock is trading at levels that appear to discount a significant positive surprise, making it vulnerable if results merely meet—rather than substantially exceed—the already-lowered expectations.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $72.22 | 50-Day MA | $67.58 |
| 10-Day MA | $72.05 | 100-Day MA | $63.94 |
| 20-Day MA | $71.93 | 200-Day MA | $63.02 |
Key support levels to watch include the 20-day moving average at $71.93 and the psychologically important 50-day average at $67.58, which aligns closely with the analyst consensus price target. The technical setup is supportive heading into earnings, with all momentum indicators pointing higher, but the extended nature of the rally and the bearish fundamental backdrop create an asymmetric risk profile: the stock may need a substantial beat to maintain current levels, while any disappointment could trigger a sharp reversal toward the $67-$68 support zone where technical and fundamental expectations converge.